SynthesisAlimentary pharmacology & therapeutics2021

Systematic review: societal cost of illness of inflammatory bowel disease is increasing due to biologics and varies between continents.

Reinier Cornelis Anthonius van Linschoten et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.